Literature DB >> 18669440

Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate.

Robert M Prins, Timothy F Cloughesy, Linda M Liau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18669440      PMCID： PMC2775501          DOI： 10.1056/NEJMc0804818

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001.

Authors:  Sundeep Deorah; Charles F Lynch; Zita A Sibenaller; Timothy C Ryken
Journal:  Neurosurg Focus       Date:  2006-04-15       Impact factor: 4.047

2.  Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment.

Authors:  Linda M Liau; Robert M Prins; Sylvia M Kiertscher; Sylvia K Odesa; Thomas J Kremen; Adrian J Giovannone; Jia-Wei Lin; Dennis J Chute; Paul S Mischel; Timothy F Cloughesy; Michael D Roth
Journal:  Clin Cancer Res       Date:  2005-08-01       Impact factor: 12.531

3.  Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma.

Authors:  Duane A Mitchell; Weihua Xie; Robert Schmittling; Chris Learn; Allan Friedman; Roger E McLendon; John H Sampson
Journal:  Neuro Oncol       Date:  2007-10-19       Impact factor: 12.300

4.  Cytomegalovirus infection of cerebral astrocytoma in an AIDS patient.

Authors:  K L Ho; C Gottlieb; R J Zarbo
Journal:  Clin Neuropathol       Date:  1991 May-Jun       Impact factor: 1.368

5.  Human cytomegalovirus infection and expression in human malignant glioma.

Authors:  Charles S Cobbs; Lualhati Harkins; Minu Samanta; G Yancey Gillespie; Suman Bharara; Peter H King; L Burt Nabors; C Glenn Cobbs; William J Britt
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701
  5 in total
  78 in total

Review 1.  Immunotherapy approaches for malignant glioma from 2007 to 2009.

Authors:  Laura A Johnson; John H Sampson
Journal:  Curr Neurol Neurosci Rep       Date:  2010-07       Impact factor: 5.081

2.  Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma.

Authors:  Alexia Ghazi; Aidin Ashoori; Patrick J Hanley; Vita S Brawley; Donald R Shaffer; Yvonne Kew; Suzanne Z Powell; Robert Grossman; Zakaria Grada; Michael E Scheurer; Meenakshi Hegde; Ann M Leen; Catherine M Bollard; Cliona M Rooney; Helen E Heslop; Stephen Gottschalk; Nabil Ahmed
Journal:  J Immunother       Date:  2012 Feb-Mar       Impact factor: 4.456

3.  Consensus on the role of human cytomegalovirus in glioblastoma.

Authors:  Kristine Dziurzynski; Susan M Chang; Amy B Heimberger; Robert F Kalejta; Stuart R McGregor Dallas; Martine Smit; Liliana Soroceanu; Charles S Cobbs
Journal:  Neuro Oncol       Date:  2012-02-08       Impact factor: 12.300

4.  The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice.

Authors:  Gerold Bongers; David Maussang; Luciana R Muniz; Vanessa M Noriega; Alberto Fraile-Ramos; Nick Barker; Federica Marchesi; Nanthakumar Thirunarayanan; Henry F Vischer; Lihui Qin; Lloyd Mayer; Noam Harpaz; Rob Leurs; Glaucia C Furtado; Hans Clevers; Domenico Tortorella; Martine J Smit; Sergio A Lira
Journal:  J Clin Invest       Date:  2010-10-11       Impact factor: 14.808

Review 5.  Oncomodulation by human cytomegalovirus: evidence becomes stronger.

Authors:  Martin Michaelis; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2009-02-07       Impact factor: 3.402

Review 6.  Toward effective immunotherapy for the treatment of malignant brain tumors.

Authors:  Duane A Mitchell; John H Sampson
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

7.  Response to "Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics".

Authors:  Charles Cobbs
Journal:  Neuro Oncol       Date:  2014-10-13       Impact factor: 12.300

Review 8.  The roles of viruses in brain tumor initiation and oncomodulation.

Authors:  Alexander Kofman; Lucasz Marcinkiewicz; Evan Dupart; Anton Lyshchev; Boris Martynov; Anatolii Ryndin; Elena Kotelevskaya; Jay Brown; David Schiff; Roger Abounader
Journal:  J Neurooncol       Date:  2011-07-01       Impact factor: 4.130

9.  Inflammation and Gliomagenesis: Bi-Directional Communication at Early and Late Stages of Tumor Progression.

Authors:  Rui Pedro Galvão; Hui Zong
Journal:  Curr Pathobiol Rep       Date:  2013-03-01

Review 10.  Chronic viral infection and primary central nervous system malignancy.

Authors:  Robert Saddawi-Konefka; John R Crawford
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.